A new medication that combines an already approved drug with a new unapproved one has been shown to cut the level of LDL, or “bad” cholestero l, when statins aren’t helping enough. In the Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback